Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp7 | Clinical case posters | ECTS2013

Severe pregnancy- and lactation-associated osteoporosis: teriparatide treatment

Lampropoulou-Adamidou Kalliopi , Kosmidis Christos , Stathopoulos Ioannis P , Papaioannou Nikolaos A , Trovas George

Introduction: Pregnancy- and lactation-associated osteoporosis (PLO) is an uncommon disease. The majority of cases are seen in the third trimester or early post-partum in the primagravid women and the prominent clinical feature of PLO is the severe and prolonged back pain and height loss. To date the prevalence and the aetiology of this disorder are unclear and there are no guidelines for its treatment.Case report: We report the outcomes of teri...

ba0001pp6 | Clinical case posters | ECTS2013

Diagnosis of fibrous dysplasia with DNA tests

Stathopoulos Ioannis , Balanika Alexia , Baltas Christos , Lampropoulou-Adamidou Kalliopi , Koromila Theodora , Kollia Panagoula , Tournis Symeon , Papaioannou Nikolaos , Katsalira Aikaterini

Introduction: Fibrous dysplasia (FD) of bone is a benign, non-inheritable disease characterized by bone pain, bone deformities and fractures. Its prevalence is ~1 in 30 000 individuals and diagnosis is based on the clinical and radiologic findings and is confirmed by biopsy. Yet, in some cases biopsy is not applicable.Case report: A young woman presented to our outpatient clinic with a history of pain localized at the distal half of the left tibia that h...

ba0001pp5 | Clinical case posters | ECTS2013

Late onset autosomal dominant hypophosphatemic rickets; confirmation of the diagnosis with genomic analysis

Tournis Symeon , Stathopoulos Ioannis , Lampropoulou-Adamidou Kalliopi , Koromila Theodora , Chatzistamatas Nikolaos , Droggaris Michail , Zafeiris Christos , Makris Konstantinos , Marketou Helen , Papaioannou Nikolaos , Kollia Panagoula , Gazi Gazi

Introduction: Autosomal dominant hypophosphatemic rickets (ADHR) is a rare form of inherited isolated renal phosphate wasting with two distinct clinical phenotypes; early-onset and late-onset. Late-onset ADHR is characterized by normal phosphate levels and growth during childhood, followed by osteomalacia with bone pain, pseudofractures and weakness in adolescence or adulthood, but with no lower extremity deformities. Most of the late-onset ADHR patients are women and pregnanc...

ba0002p100 | (1) | ICCBH2013

Preliminary evidence of reduced volumetric trabecular bone mineral density in children with idiopathic hypercalciuria: a peripheral quantitative computed tomography study

Atsali Erato , Stathopoulos Konstantinos D , Bournazos Ilias , Nikolaidou Polyxeni , Papagelopoulos Panagiotis , Zoubos Aristides B , Skarantavos Grigoris

Objective: Idiopathic hypercalciuria (IH) is defined as excessive 24 h urinary calcium excretion (>4 mg/kg per 24 h), that persists after correction of dietary imbalances in the absence of secondary causes. Recent studies with DXA in children with IH provide evidence of decreased areal BMD. We used peripheral quantitative computed tomography (pQCT) of the tibia, to test the hypothesis that IH results in decreases of volumetric (mg/cm3) BMD of the trabecular and/...

ba0001pp473 | Other diseases of bone and mineral metabolism | ECTS2013

Evidence of increased bone resorption in early post menopausal women with idiopathic hypercalciuria: study with biochemical markers and pQCT of the Tibia

Stathopoulos Konstantinos , Bournazos Ilias , Katsimbri Pelagia , Partsinevelos Andonios , Zoubos Aristeides B , Papaggelopoulos Panagiotis , Atsali Erato , Skarandavos Grigoris

Aim: We explored the hypothesis that idiopathic hypercalciuria (IH) causes increased bone loss in early post-menopausal women.Materials and methods: We studied 41 postmenopausal women with IH. Inclusion criteria: i) recently (<6 months) diagnosed and untreated IH, ii) postmenopausal status >2 years, and iii) normal renal function. Exclusion criteria: i) all causes of hypercalciuria other than IH and ii) use of any medication for osteoporosis 1-ye...

ba0003pp388 | Other diseases of bone and mineral metabolism | ECTS2014

Late onset presentation of osteogenesis imperfecta with additional mutation on GNAS gene: case report

Stathopoulos Konstantinos D , Koromila Theodora , Paschalis Eleftherios P , Soultanis Konstantinos , Atsali Erato , Bournazos Ilias , Damianou Eirini , Zoubos Aristides B , Papaggelopoulos Panagiotis J , Skarantavos Grigoris

Aim: We present the case of a 36y female patient with multiple fragility fractures after the age of 21 and mutations in COL1A1, COL1A2 and GNAS genes.Material and methods: A 36y female patient with multiple fractures of the axial and appendicular skeleton was referred to us for consultation. The patient was born with hexadactyly of the left foot and had a history of mild thoracolumbar scoliosis (10°) and medium height (165 cm) with no other history ...

ba0003pp272 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

Serum 25-hydroxyvitamin D levels of healthy adult women in Greece

Grigoriou Efi , Trovas George , Dontas Ismini , Papaioannou Nikolaos , Stathopoulou Maria , Dedoussis George

Objective: The objective of this observational cross-sectional study is to identify the prevalence of vitamin D deficiency in healthy women in Greece, as reflected by the levels of 25-hydroxyvitamin D (25(OH)D), since recent data indicate that vitamin D deficiency can be common in countries previously considered as low risk (e.g. Mediterranean countries).Materials and methods: A population of 840 community dwelling women was recruited at the health promo...

ba0002p6 | (1) | ICCBH2013

The relationship between bone health and body composition profile in patients with galactose metabolic disorders: implications for practice

Doulgeraki Artemis , Monopolis Ioannis , Deligianni Domna , Kalogerakou Maria , Schulpis Kleopatra

Objectives: To evaluate bone health and its possible correlations to body composition parameters in young patients with galactose metabolic disorders, aiming to suggest appropriate lifestyle interventions.Methods: We studied 22 patients, aged 5–16 years with galactose metabolic disorders, detected by neonatal screening. Fourteen suffered from classic galactosemia and eight from other galactose metabolic disorders (i.e. epimerase or galactokinase def...

ba0002p14 | (1) | ICCBH2013

Bone status and body composition analysis in young patients with phenylketonuria and hyperphenylalaninemia

Doulgeraki Artemis , Monopolis Ioannis , Skarpalezou Astrinia , Theodosiadou Areti , Schulpis Kleopatra

Objectives: To evaluate bone status and body composition in patients with phenylketonuria and hyperphenylalaninemia.Methods: Eighty patients (48 with phenylketonuria and 32 with hyperphenylalaninemia), aged 5–18 years, early-diagnosed, underwent dual energy X-ray absorptiometry. Bone mineral density (lumbar spine and total body), bone strength (bone mineral content:lean tissue mass ratio), lean tissue mass, body fat percentage, and fat mass index we...

ba0006lb20 | (1) | ICCBH2017

COL2A1 c.1609G>A (p.Gly537Ser) a pathogenic variant causing multiple skeletal abnormalities and severe short stature

Vlachopapadopoulou Elpis , Dikaiakou Irene , Manolakos Emmanouil , Panagiotopoulos Ioannis , Michalacos Stefanos

Background: Skeletal dysplasias include many pathological conditions that involve bone metabolism and health and most of them are associated with short stature. 211 genes are associated with bone dysplasia and short stature. Presenting problem: To present a boy with severe short stature and skeletal abnormalities. He was born at term AGA. Growth failure was noted from the age of 8 months. IGF-I levels were low and he was tested for growth hormone deficie...